Evidence map›Paper›PMID 38702349›Full record

ArticleBlood cancer journal2024

A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping.

Ying S Zou, Melanie Klausner, Jen Ghabrial, Victoria Stinnett, Patty Long, Laura Morsberger, Jaclyn B Murry, Katie Beierl, Christopher D Gocke, Rena R Xian and 8 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Chromoanagenesis in Multiple Myeloma: A Comprehensive Overview.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ying S ZouDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. yzou19@jhmi.edu.ORCID 0000-0003-2787-1917
Melanie KlausnerDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jen GhabrialDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Victoria StinnettDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Patty LongDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Laura MorsbergerDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jaclyn B MurryDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Katie BeierlDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christopher D GockeDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-9541-2192
Rena R XianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kevin H ToomerDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jing Christine YeDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Robert Z OrlowskiDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Carol Ann HuffDepartment of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Syed Abbas AliDepartment of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Philip H ImusDepartment of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christian B GockeDepartment of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Guilin TangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.ORCID 0000-0002-9482-4806

Funding

Role of Heat Shock Protein 70 as a Mediator and Therapeutic Target in T-cell LymphomasR01CA266612 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Javeed Iqbal, ROBERT ZYGMUNT ORLOWSKI · 2022 to 2026
$2.4M
Role of Oncogenic RAS in Multiple Myeloma Disease ProgressionK08CA218893 · NCI · JOHNS HOPKINS UNIVERSITY · PI GOCKE, CHRISTIAN B · 2018 to 2022
$1.1M
NCI NIH HHS K08 CA218893NCI NIH HHS R01 CA266612
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaChromosome AberrationsChromosome MappingHumans

Identifiers

PMID38702349
PMCPMC11068911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.